241 related articles for article (PubMed ID: 19784856)
1. Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the CSF of patients with Alzheimer's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process.
Isobe C; Abe T; Terayama Y
J Neurol; 2010 Mar; 257(3):399-404. PubMed ID: 19784856
[TBL] [Abstract][Full Text] [Related]
2. Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process.
Isobe C; Abe T; Terayama Y
Neurosci Lett; 2010 Jan; 469(1):159-63. PubMed ID: 19944739
[TBL] [Abstract][Full Text] [Related]
3. Increase in the oxidized/total coenzyme Q-10 ratio in the cerebrospinal fluid of Alzheimer's disease patients.
Isobe C; Abe T; Terayama Y
Dement Geriatr Cogn Disord; 2009; 28(5):449-54. PubMed ID: 19907182
[TBL] [Abstract][Full Text] [Related]
4. Increased mitochondrial oxidative damage and oxidative DNA damage contributes to the neurodegenerative process in sporadic amyotrophic lateral sclerosis.
Murata T; Ohtsuka C; Terayama Y
Free Radic Res; 2008 Mar; 42(3):221-5. PubMed ID: 18344116
[TBL] [Abstract][Full Text] [Related]
5. Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosis.
Murata T; Ohtsuka C; Terayama Y
J Neurol Sci; 2008 Apr; 267(1-2):66-9. PubMed ID: 17961597
[TBL] [Abstract][Full Text] [Related]
6. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF.
Lovell MA; Gabbita SP; Markesbery WR
J Neurochem; 1999 Feb; 72(2):771-6. PubMed ID: 9930752
[TBL] [Abstract][Full Text] [Related]
7. 8OHdG levels in brain do not indicate oxidative DNA damage in Alzheimer's disease.
Te Koppele JM; Lucassen PJ; Sakkee AN; Van Asten JG; Ravid R; Swaab DF; Van Bezooijen CF
Neurobiol Aging; 1996; 17(6):819-26. PubMed ID: 9363791
[TBL] [Abstract][Full Text] [Related]
8. Detection and quantification of 8-hydroxy-2'-deoxyguanosine in Alzheimer's transgenic mouse urine using capillary electrophoresis.
Zhang C; Nestorova G; Rissman RA; Feng J
Electrophoresis; 2013 Aug; 34(15):2268-74. PubMed ID: 23712533
[TBL] [Abstract][Full Text] [Related]
9. Urinary 8-hydroxy-2'-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer's disease.
Zengi O; Karakas A; Ergun U; Senes M; Inan L; Yucel D
Clin Chem Lab Med; 2011 Nov; 50(3):529-34. PubMed ID: 22098435
[TBL] [Abstract][Full Text] [Related]
10. Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson's disease.
Isobe C; Murata T; Sato C; Terayama Y
J Clin Neurosci; 2007 Apr; 14(4):340-3. PubMed ID: 16647853
[TBL] [Abstract][Full Text] [Related]
11. DNA versus RNA oxidation in Parkinson's disease: Which is more important?
Gmitterová K; Gawinecka J; Heinemann U; Valkovič P; Zerr I
Neurosci Lett; 2018 Jan; 662():22-28. PubMed ID: 28963060
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
13. Correlations between oxidative DNA damage, oxidative stress and coenzyme Q10 in patients with coronary artery disease.
Kaya Y; Çebı A; Söylemez N; Demır H; Alp HH; Bakan E
Int J Med Sci; 2012; 9(8):621-6. PubMed ID: 23055813
[TBL] [Abstract][Full Text] [Related]
14. Genistein alleviates the mitochondria-targeted DNA damage induced by β-amyloid peptides 25-35 in C6 glioma cells.
Ma WW; Hou CC; Zhou X; Yu HL; Xi YD; Ding J; Zhao X; Xiao R
Neurochem Res; 2013 Jul; 38(7):1315-23. PubMed ID: 23519932
[TBL] [Abstract][Full Text] [Related]
15. Effect of oxidative stress on DNA damage and beta-amyloid precursor proteins in lymphoblastoid cell lines from a Nigerian population.
Lahiri DK; Xu Y; Klaunig J; Baiyewu O; Ogunniyi A; Hall K; Hendrie H; Sahota A
Ann N Y Acad Sci; 1999; 893():331-6. PubMed ID: 10672260
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and oxidative DNA damage is characteristic for mixed Alzheimer disease/vascular dementia.
Gackowski D; Rozalski R; Siomek A; Dziaman T; Nicpon K; Klimarczyk M; Araszkiewicz A; Olinski R
J Neurol Sci; 2008 Mar; 266(1-2):57-62. PubMed ID: 17888453
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease.
de la Monte SM; Luong T; Neely TR; Robinson D; Wands JR
Lab Invest; 2000 Aug; 80(8):1323-35. PubMed ID: 10950123
[TBL] [Abstract][Full Text] [Related]
18. Increase of oxidative stress in human sperm with lower motility.
Kao SH; Chao HT; Chen HW; Hwang TIS; Liao TL; Wei YH
Fertil Steril; 2008 May; 89(5):1183-1190. PubMed ID: 17669405
[TBL] [Abstract][Full Text] [Related]
19. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease.
Mecocci P; MacGarvey U; Beal MF
Ann Neurol; 1994 Nov; 36(5):747-51. PubMed ID: 7979220
[TBL] [Abstract][Full Text] [Related]
20. 8-OHdG in cerebrospinal fluid as a marker of oxidative stress in various neurodegenerative diseases.
Gmitterová K; Heinemann U; Gawinecka J; Varges D; Ciesielczyk B; Valkovic P; Benetin J; Zerr I
Neurodegener Dis; 2009; 6(5-6):263-9. PubMed ID: 19955696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]